Author

Mengmeng Wang

Observed name: WANG Mengmeng

Institutions: Weifang Medical University, Shandong University, Henan University of Science and Technology, Second Hospital of Shandong University, Weihai Municipal Hospital

Observed institutions: Shenyang Pharmaceutical University, Weifang Medical University, Shandong University, Henan University of Science and Technology, Second Hospital of Shandong University, Weihai Municipal Hospital

ORCID: 0009-0008-9283-100X

Observed ORCID: 0009-0008-9283-100X

OpenAlex ID: A5041371780

The efficacy and safety of continuous intravenous tirofiban for acute ischemic stroke patients treated by endovascular therapy: a meta-analysis

2024 · Mengmeng Wang, Jing Li, et al. · Frontiers in Neurology · 10

Syndrome of inappropriate antidiuretic hormone secretion is associated with different proton pump inhibitor use: a pharmacovigilance study

2022 · Mengmeng Wang, Lingjian Zhang, et al. · BMC Nephrology · 9

A real-world disproportionality analysis of Tivozanib data mining of the public version of FDA adverse event reporting system

2024 · Kaixuan Wang, Mengmeng Wang, et al. · Frontiers in Pharmacology · 7

The effectiveness and safety of human urinary kallidinogenase in acute ischemic stroke patients undergoing endovascular therapy

2024 · Mengmeng Wang, Changwei Guo, et al. · Journal of Cerebral Blood Flow & Metabolism · 4

Endovascular Therapy for Basilar Artery Occlusion in Sudden Onset to Maximal Deficit Ischemic Events

2024 · Lina Zhu, Wenhua Liu, et al. · Journal of the American Heart Association · 2

Aneurysm and Artery Dissection Following the use of Vascular Endothelial Growth Factor Inhibitor: A Real-World Analysis Using a Spontaneous Reporting System

2020 · Jian Gong, WANG Shuyue, et al. · Research Square

Works count: 6

Citation count: 32

H-index: 4

I10-index: 1